The US stock of Hims & Hers, an affordable diet drug concept stock, fell 13% before the market. Earlier, the US Food and Drug Administration said that the shortage of supply of Tirzepatide injections of Eli Lilly's diet medicine has been dealt with.

The US stock of Hims & Hers, an affordable diet drug concept stock, fell 13% before the market. Earlier, the US Food and Drug Administration said that the shortage of supply of Tirzepatide injections of Eli Lilly's diet medicine has been dealt with.